Skip to main content

Table 4 Incidence of major adverse events that caused discontinuation of treatment

From: The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil

Adverse events

Incidence of occurrence, n (%)

Laboratory abnormality

n = 16

  Anaemia

11 (68.7)

  Thrombocytopenia/neutropenia

15 (93.7)

Death

n = 8

  Acute myocardial infarction

1 (12.5)

  Pneumonia and sepsis

2 (25)

  Acute respiratory failure

2 (25)

  Encephalopathy/ascites

2 (25)

  Cause unknown

1 (12.5)